DL Longo
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- T-cell and Retrovirus Studies
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 9
- Chronic Lymphocytic Leukemia Research 8
-
- Chronic Myeloid Leukemia Treatments 4
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Margaret BeckwithGalia TsarfatyCA KollerKA FoonRG SteisW J MurphyLuigi VaresioDiana Linnekin
- Journals
- Blood (28 papers)International Journal of Oncology (1 paper)PubMed (2 papers)
- Partner nations
- United StatesMalaysiaGermany
In The Last Decade
DL Longo
31 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Immunology 603
- Genetics 233
- Hematology 232
- Pathology and Forensic Medicine 323
- Oncology 400
Countries citing papers authored by DL Longo
This map shows the geographic impact of DL Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DL Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DL Longo more than expected).
Fields of papers citing papers by DL Longo
This network shows the impact of papers produced by DL Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DL Longo. The network helps show where DL Longo may publish in the future.
Co-authors
The 25 scholars most cited alongside DL Longo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 21 | |
| 2 | 1996 | 102 | |
| 3 | 1996 | 26 | |
| 4 | In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts. | 1995 | 69 |
| 5 | 1995 | 3 | |
| 6 | 1995 | 85 | |
| 7 | 1994 | 54 | |
| 8 | 1994 | 193 | |
| 9 | 1994 | 1 | |
| 10 | 1992 | 4 | |
| 11 | 1992 | 2 | |
| 12 | 1992 | 41 | |
| 13 | 1990 | 4 | |
| 14 | 1989 | 2 | |
| 15 | Randomized trial of recombinant alpha 2b-interferon with or without indomethacin in patients with metastatic malignant melanoma. | 1989 | 32 |
| 16 | 1986 | 149 | |
| 17 | 1983 | 5 | |
| 18 | 1978 | 9 | |
| 19 | 1977 | 1 | |
| 20 | 1977 | 1 |
About DL Longo
DL Longo is a scholar working on Genetics, Hematology, Immunology, Oncology and Biological Psychiatry, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Immune Cell Function and Interaction (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Immunology (603 citations), Genetics (233 citations), Hematology (232 citations), Pathology and Forensic Medicine (323 citations) and Oncology (400 citations). DL Longo has collaborated with scholars based in United States, Malaysia and Germany. Frequent co-authors include Margaret Beckwith, Galia Tsarfaty, CA Koller, KA Foon, RG Steis, W J Murphy, Luigi Varesio, Diana Linnekin, D K Ferris and GL Gusella. Their work appears in journals such as Blood, International Journal of Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.